CYB5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.270000E-01
Normal-vs-Stage2
4.438200E-01
Normal-vs-Stage3
9.435800E-01
Normal-vs-Stage4
3.275200E-01
Stage1-vs-Stage2
9.884400E-01
Stage1-vs-Stage3
5.144200E-01
Stage1-vs-Stage4
9.660800E-01
Stage2-vs-Stage3
3.314800E-01
Stage2-vs-Stage4
9.479800E-01
Stage3-vs-Stage4
5.017800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.334000E-01
Normal-vs-AfricanAmerican
2.946200E-01
Normal-vs-Asian
2.628600E-01
Caucasian-vs-AfricanAmerican
4.129200E-01
Caucasian-vs-Asian
3.081600E-01
AfricanAmerican-vs-Asian
5.558400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.070800E-01
Normal-vs-Female
6.412400E-01
Male-vs-Female
2.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.610000E-01
Normal-vs-Age(41-60Yrs)
3.032800E-01
Normal-vs-Age(61-80Yrs)
6.215600E-01
Normal-vs-Age(81-100Yrs)
2.301000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.705200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.686400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.237600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.989400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.575800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.993200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.584200E-01
Normal-vs-Daily Drinker
1.306560E-01
Normal-vs-Weekly Drinker
5.943800E-01
Normal-vs-Occasional Drinker
3.119800E-01
Normal-vs-Social Drinker
6.336200E-01
Non Drinker-vs-Daily Drinker
3.577000E-01
Non Drinker-vs-Weekly Drinker
9.648200E-01
Non Drinker-vs-Occasional Drinker
2.486400E-01
Non Drinker-vs-Social Drinker
8.018600E-01
Daily Drinker-vs-Weekly Drinker
3.905200E-01
Daily Drinker-vs-Occasional Drinker
8.625800E-01
Daily Drinker-vs-Social Drinker
2.787000E-01
Weekly Drinker-vs-Occasional Drinker
3.215000E-01
Weekly Drinker-vs-Social Drinker
7.618000E-01
Occasional Drinker-vs-Social Drinker
1.695970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.571400E-01
Normal-vs-Grade 2
4.264200E-02
Normal-vs-Grade 3
1.541580E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.856700E-03
Grade 1-vs-Grade 3
2.659100E-03
Grade 1-vs-Grade 4
1.571400E-01
Grade 2-vs-Grade 3
8.246800E-01
Grade 2-vs-Grade 4
4.264200E-02
Grade 3-vs-Grade 4
1.541580E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.045200E-01
Normal-vs-NonDiabetic
5.189600E-01
Diabetic-vs-NonDiabetic
1.178370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.701200E-01
Normal-vs-NoPancreatitis
5.365400E-01
Pancreatitis-vs-NoPancreatitis
3.862800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.798400E-01
Normal-vs-N1
4.808600E-01
N0-vs-N1
3.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.02440000000226E-05
Normal-vs-TP53-NonMutant
2.807600E-01
TP53-Mutant-vs-TP53-NonMutant
7.94720000000249E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
